Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A single session of 1 mA anodal tDCS-supported motor training does not improve motor performance in patients with multiple sclerosis.
Impact of Sativex(®) on quality of life and activities of daily living in patients with multiple sclerosis spasticity.
Associated Inosine to interferon: results of a clinical trial in multiple sclerosis.
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis.
Temperature dependence of water diffusion pools in brain white matter.
How does magnetization transfer influence mcDESPOT results?
Fingolimod Reduces Direct Medical Costs Compared to Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis in the Netherlands.
The effectiveness of fingolimod in a Portuguese real-world population.
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective.
Knee muscle strength in multiple sclerosis: relationship with gait characteristics.
Effect of comorbidity on mortality in multiple sclerosis.
Improving Multiple Sclerosis Plaque Detection Using a Semiautomated Assistive Approach.
Central and peripheral demyelination.
Role of vitamin D in acquired immune and autoimmune diseases.
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
Clinical Overview of Dalfampridine: An Agent With a Novel Mechanism of Action to Help With Gait Disturbances.
Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment.
Myelitis: Differences between multiple sclerosis and other aetiologies.
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications.
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab.
Bilateral hypogeusia caused by a small lesion in the lower midbrain tegmentum.
The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation.
Adult-onset vanishing white matter disease as differential diagnosis of primary progressive multiple sclerosis: A case report.
Silent aspiration and recovery from Dysphagia in a case of bickerstaff brainstem encephalitis.
Determinant spreading and the dynamics of the autoimmune T-cell repertoire.
Pages
« first
‹ previous
…
379
380
381
382
383
384
385
386
387
…
next ›
last »